In agreement, minimal dosing of leukocyte-targeting TRAIL via administration of E-selectin-TRAIL liposomes decreased triple-negative breast cancer metastasis following tumor resection in a preclinical mouse model [30]. The gene discussed is TNFSF10; the disease is neoplasm.